GD
Grandfield & Dodd Portfolio holdings
AUM
$1.71B
This Quarter Return
+7.55%
1 Year Return
+14.85%
3 Year Return
+57.47%
5 Year Return
+112%
10 Year Return
+284.72%
AUM
$1.45B
AUM Growth
+$1.45B
(+8%)
Cap. Flow
+$14.1M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
32.25%
Holding
206
New
9
Increased
77
Reduced
52
Closed
2
Top Buys
| 1 |
Teledyne Technologies
TDY
|
$6.58M |
| 2 |
Hexcel
HXL
|
$1.8M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$1.72M |
| 4 |
Gilead Sciences
GILD
|
$1.4M |
| 5 |
RTX Corp
RTX
|
$1.24M |
Top Sells
| 1 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
$12.6M |
| 2 |
PayPal
PYPL
|
$1.1M |
| 3 |
eBay
EBAY
|
$976K |
| 4 |
Microsoft
MSFT
|
$860K |
| 5 |
Applied Materials
AMAT
|
$509K |
Sector Composition
| 1 | Technology | 28.78% |
| 2 | Healthcare | 14.81% |
| 3 | Financials | 13.3% |
| 4 | Industrials | 12.8% |
| 5 | Consumer Staples | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
SPDR S&P 500 ETF Trust
SPY
$658B
| $2M | 0.14% |
4,663
| – | – |
|
77
Honeywell
HON
$139B
| $1.96M | 0.14% |
8,946
-40
| -0.4% | -$8.76K |
|
78
Colgate-Palmolive
CL
$67.9B
| $1.9M | 0.13% |
23,356
| – | – |
|
79
Nutrien
NTR
$28B
| $1.88M | 0.13% |
30,960
| – | – |
|
80
Abbott
ABT
$231B
| $1.83M | 0.13% |
15,784
-696
| -4% | -$80.7K |
|
81
Amazon
AMZN
$2.44T
| $1.79M | 0.12% |
521
+19
| +4% | +$65.3K |
|
82
Home Depot
HD
$405B
| $1.75M | 0.12% |
5,486
+79
| +1% | +$25.2K |
|
83
Vertex Pharmaceuticals
VRTX
$100B
| $1.6M | 0.11% |
7,932
+70
| +0.9% | +$14.1K |
|
84
Fastenal
FAST
$57B
| $1.55M | 0.11% |
29,856
| – | – |
|
85
Intuitive Surgical
ISRG
$170B
| $1.43M | 0.1% |
1,558
| – | – |
|
|
JWN
86
DELISTED
Nordstrom
JWN
| $1.42M | 0.1% |
38,713
+2,133
| +6% | +$78.2K |
|
87
Automatic Data Processing
ADP
$123B
| $1.32M | 0.09% |
6,643
-20
| -0.3% | -$3.97K |
|
88
Emerson Electric
EMR
$74.3B
| $1.29M | 0.09% |
13,370
| – | – |
|
|
ALXN
89
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.29M | 0.09% |
7,016
-356
| -5% | -$65.5K |
|
90
Bristol-Myers Squibb
BMY
$96B
| $1.27M | 0.09% |
19,014
+281
| +2% | +$18.8K |
|
91
Target
TGT
$43.6B
| $1.23M | 0.09% |
5,091
| – | – |
|
92
Union Pacific
UNP
$133B
| $1.18M | 0.08% |
5,364
-24
| -0.4% | -$5.28K |
|
93
Visa
V
$683B
| $1.17M | 0.08% |
5,018
+158
| +3% | +$36.8K |
|
94
Neurocrine Biosciences
NBIX
$13.8B
| $1.14M | 0.08% |
11,743
+190
| +2% | +$18.4K |
|
95
GE Aerospace
GE
$292B
| $1.1M | 0.08% |
82,016
-200
| -0.2% | -$2.68K |
|
96
Incyte
INCY
$16.5B
| $1.08M | 0.07% |
12,860
+215
| +2% | +$18.1K |
|
97
Kimberly-Clark
KMB
$42.8B
| $1.03M | 0.07% |
7,720
-200
| -3% | -$26.7K |
|
98
Waters Corp
WAT
$18B
| $1.01M | 0.07% |
2,910
| – | – |
|
99
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $990K | 0.07% |
15,600
| – | – |
|
100
BioMarin Pharmaceuticals
BMRN
$11.2B
| $980K | 0.07% |
11,734
+215
| +2% | +$18K |
|